Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

25
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
25
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

25
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
25
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

15
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
15
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

5.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.7K
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

1.6K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Longitudinal, Real-World Study of the Relationship between Levothyroxine Dose and Suboptimal Hypothyroidism Treatment.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Impact of Hypothyroidism on Short-Term and Long-Term Outcomes of Coronary Artery Bypass Graft Surgery.

Thyroid : official journal of the American Thyroid Association·2026
Same author

A Phase 2 Study of XP-8121: Once-Weekly Subcutaneous Levothyroxine Sodium for the Treatment of Hypothyroidism in Adults.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Overnutrition in mice impairs thyroid hormone biosynthesis and utilization, causing hypothyroidism, despite remarkable thyroidal adaptations.

The Journal of clinical investigation·2026
Same author

Thyroid Hormone Synthesis Without Thyroglobulin.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Response to Letter to the Editor from Hedberg et al: "Treatment of Hypothyroidism That Contains Liothyronine Is Associated With Reduced Risk of Dementia and Mortality".

The Journal of clinical endocrinology and metabolism·2025

Related Experiment Video

Updated: Apr 26, 2026

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
07:37

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells

Published on: November 17, 2017

14.4K

Defending plasma T3 is a biological priority.

Sherine M Abdalla1, Antonio C Bianco

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.

Clinical Endocrinology
|July 22, 2014
PubMed
Summary

Serum triiodothyronine (T3) levels remain stable despite changes in thyroxine (T4) and TSH. This highlights the importance of T3 monitoring and potential combination therapy for hypothyroidism patients who remain symptomatic on levothyroxine alone.

More Related Videos

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

7.5K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.1K

Related Experiment Videos

Last Updated: Apr 26, 2026

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
07:37

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells

Published on: November 17, 2017

14.4K
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

7.5K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.1K

Area of Science:

  • Endocrinology
  • Thyroid Hormone Physiology
  • Metabolic Regulation

Background:

  • Triiodothyronine (T3) is the active thyroid hormone, primarily produced extrathyroidally from thyroxine (T4).
  • The hypothalamus-pituitary-thyroid axis and deiodinase activity regulate plasma T3 levels, ensuring stability in healthy individuals.
  • Rodent studies show stable T3 despite disruptions in feedback mechanisms, with T4 and TSH levels increasing.

Purpose of the Study:

  • To examine the clinical implications of serum T3 levels in thyroid disease management.
  • To evaluate the effectiveness of current hypothyroidism treatment strategies, particularly levothyroxine monotherapy.
  • To explore the rationale for combination therapy in patients with persistent symptoms.

Main Methods:

  • Review of existing literature on thyroid hormone metabolism and regulation.
  • Analysis of findings from rodent studies on feedback disruption.
  • Clinical observations regarding patient responses to levothyroxine monotherapy versus combination therapy.

Main Results:

  • Serum T3 levels demonstrate remarkable stability, even with significant alterations in thyroxine (T4) and thyroid-stimulating hormone (TSH).
  • Levothyroxine monotherapy does not normalize serum T3 in all hypothyroid patients.
  • A subset of patients remain symptomatic despite normalized TSH levels on levothyroxine.

Conclusions:

  • Serum T3 stability underscores its critical role in thyroid hormone homeostasis.
  • The limitations of levothyroxine monotherapy suggest a need for alternative or adjunctive treatments.
  • Combination therapy with levothyroxine and liothyronine may benefit hypothyroid patients with persistent symptoms and suboptimal T3 levels.